PAHC
PHIBRO ANIMAL HEALTH CORP
Key Financials
Operating Income
$110.5M
↑ 107.2%
Gross Profit
$399.9M
↑ 27.7%
EPS (Diluted)
$1.19
↑ 1883.3%
Net Income
$48.3M
↑ 1897.7%
Total Assets
$1.4B
↑ 38.6%
Total Liabilities
$1.1B
↑ 48.2%
Shareholders' Equity
$285.7M
↑ 11.3%
Revenue
$1.3B
↑ 27.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/16/2026 | View on SEC |
| 8-K | 4/14/2026 | View on SEC |
| SCHEDULE 13G | 4/7/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/19/2026 | View on SEC |
| 4 | 3/16/2026 | View on SEC |
| 144 | 3/13/2026 | View on SEC |
| 4 | 2/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PAHC |
| Company Name | PHIBRO ANIMAL HEALTH CORP |
| CIK | 1069899 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 201-329-7300 |